Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 17:46 | 2/8/24 | SANA | Health | BioPrd | Biological Products, (No Diag | Nelsen Robert | IL | DT | P | 10,000 | 5.50 | 0 | 1,818 | 9 | 22,761 | I | |||||||||||||||
2/12/24 17:43 | 2/8/24 | SANA | Health | BioPrd | Biological Products, (No Diag | Crandell Keith | IL | T | P | 10,000 | 5.50 | 0 | 1,818 | 9 | 22,747 | I | |||||||||||||||
2/12/24 17:43 | 2/8/24 | SANA | Health | BioPrd | Biological Products, (No Diag | Arch Venture Fund X, L.P. | IL | T | P | 10,000 | 5.50 | 0 | 1,818 | 9 | 22,747 | I | |||||||||||||||
2/17/23 17:17 | 2/3/21 | SANA | Health | BioPrd | Biological Products, (No Diag | Bilenker Joshua H. | WA | D | P | 500 | 25.00 | 0 | 20 | New | 20 | D | |||||||||||||||
3/22/22 19:51 | 3/21/22 | SANA | Health | BioPrd | Biological Products, (No Diag | Yang Patrick Y | WA | D | P | 204 | 7.30 | 0 | 28 | 19 | 174 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |